• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 13, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Case Western Reserve University School of Medicine launches Institute for Glial Sciences

Bioengineer by Bioengineer
November 2, 2023
in Health
Reading Time: 3 mins read
0
Institute for Glial Sciences
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

CLEVELAND—Case Western Reserve University has established an Institute for Glial Sciences to advance research of glial cells and their critical role in the health and diseases of the nervous systems, including multiple sclerosis, Alzheimer’s, pediatric leukodystrophies, Autism spectrum disorders, Parkinson’s disease and cancer.

Institute for Glial Sciences

Credit: Caitlin Guttu

CLEVELAND—Case Western Reserve University has established an Institute for Glial Sciences to advance research of glial cells and their critical role in the health and diseases of the nervous systems, including multiple sclerosis, Alzheimer’s, pediatric leukodystrophies, Autism spectrum disorders, Parkinson’s disease and cancer.

Housed within the Case Western Reserve School of Medicine’s Department of Genetics and Genome Sciences, the new institute will be directed by Paul Tesar, the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics. The institute will focus on three nervous systems: the central, peripheral and enteric.

Glial cells comprise more than half of the cells in these nervous systems and work with neurons to ensure proper neurological function. Despite their importance to human health, few specialized research centers globally are dedicated to studying them.

“As we announce the Institute for Glial Sciences, we’re not just launching a research center, we’re championing a vision,” said Stan Gerson, dean and senior vice president for medical affairs at the School of Medicine. “Guided by Professor Paul Tesar’s exceptional leadership, we’re uniting innovation with impact. From our laboratories into clinical application, this institute embodies our steadfast dedication to exploring new frontiers in glial sciences and effecting real-world change.”

In addition to its core scientific pursuits, the institute will concentrate on developing new methods for studying glial cells and creating new classes of medicines targeting glial cells, Tesar said. The institute will also offer education and training opportunities to students and postdoctoral and clinical fellows eager to specialize in glial cell research and medicine.

“The Institute for Glial Sciences is a manifestation of our collective aspiration to deepen the understanding of glial cells,” Tesar said. “These integral components of our nervous systems have long been overshadowed, and through the Institute, we aim to shed light on their complexity, developing treatments that could revolutionize how we approach neurological care.”

Tesar and his team have been at the forefront of unraveling the complexities of glial cell dysfunction and its crucial role in human neurological diseases. Their pioneering work has not only deepened an understanding of these cells, but also led to groundbreaking advancements in treatments.

Among their notable achievements are the discovery of two novel classes of medicines: a remyelination therapy for multiple sclerosis, which the university licensed to Convelo Therapeutics, and an antisense oligonucleotide therapy for Pelizaeus Merzbacher disease, licensed to Ionis Pharmaceuticals and slated for clinical trials in early 2024.

“The Institute for Glial Sciences aims to build from these accomplishments,” Tesar said, “propelling new breakthroughs in glial science and offering new hope for treatment of neurological diseases.”

Tesar said the institute has already begun adding faculty and staff.

“Philanthropy has been crucial in advancing our work to this stage,” Tesar said, “and will continue to play an even more important role as we expand to impact more patients.”

                                                                        ###

Case Western Reserve University is one of the country’s leading private research institutions. Located in Cleveland, we offer a unique combination of forward-thinking educational opportunities in an inspiring cultural setting. Our leading-edge faculty engage in teaching and research in a collaborative, hands-on environment. Our nationally recognized programs include arts and sciences, dental medicine, engineering, law, management, medicine, nursing and social work. About 6,200 undergraduate and 6,100 graduate students comprise our student body. Visit case.edu to see how Case Western Reserve thinks beyond the possible.



Share12Tweet8Share2ShareShareShare2

Related Posts

Chemical Dimerization Inhibits GSDMD-Driven Pyroptosis

October 13, 2025

Psychedelic 5-HT2A Activation Changes Brain Blood Flow

October 13, 2025

Cost-Effectiveness of New TB Diagnosis Methods in Uganda

October 13, 2025

Optimizing Omadacycline Dosing for NTM-PD Treatment

October 13, 2025

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1230 shares
    Share 491 Tweet 307
  • New Study Reveals the Science Behind Exercise and Weight Loss

    103 shares
    Share 41 Tweet 26
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    100 shares
    Share 40 Tweet 25
  • Revolutionizing Optimization: Deep Learning for Complex Systems

    91 shares
    Share 36 Tweet 23

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Efficient Matrix Solving with Resistive RAM Technology

Chemical Dimerization Inhibits GSDMD-Driven Pyroptosis

Dana-Farber Leads Phase 3 Trials for Breast, Lung, and Bladder Cancer Unveiled at ESMO Congress 2025

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 64 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.